{"id":"https://openalex.org/W2559999763","doi":"https://doi.org/10.1182/blood.v124.21.2846.2846","title":"Safety and Efficacy of Nonacog Beta Pegol (N9-GP) for Prophylaxis and Treatment of Bleeding Episodes in Previously-Treated Patients with Hemophilia B: Results from an Extension Trial","display_name":"Safety and Efficacy of Nonacog Beta Pegol (N9-GP) for Prophylaxis and Treatment of Bleeding Episodes in Previously-Treated Patients with Hemophilia B: Results from an Extension Trial","publication_year":2014,"publication_date":"2014-12-06","ids":{"openalex":"https://openalex.org/W2559999763","doi":"https://doi.org/10.1182/blood.v124.21.2846.2846","mag":"2559999763"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v124.21.2846.2846","doi":"https://doi.org/10.1182/blood.v124.21.2846.2846","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v124.21.2846.2846","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004338432","display_name":"Guy A. Young","orcid":"https://orcid.org/0000-0001-6013-1254","observed_orcids":["https://orcid.org/0000-0001-6013-1254"]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]},{"id":"https://openalex.org/I1336910626","display_name":"Children's Hospital Los Angeles","ror":"https://ror.org/00412ts95","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1336910626"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Guy Young","raw_affiliation_strings":["Hemostasis and Thrombosis Center, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hemostasis and Thrombosis Center, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA","institution_ids":["https://openalex.org/I1174212","https://openalex.org/I1336910626"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065311756","display_name":"Peter W. Collins","orcid":"https://orcid.org/0000-0002-6410-1324","observed_orcids":["https://orcid.org/0000-0002-6410-1324"]},"institutions":[{"id":"https://openalex.org/I79510175","display_name":"Cardiff University","ror":"https://ror.org/03kk7td41","country_code":"GB","type":"education","lineage":["https://openalex.org/I79510175"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Peter W. Collins","raw_affiliation_strings":["Cardiff University, Cardiff, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiff University, Cardiff, United Kingdom","institution_ids":["https://openalex.org/I79510175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088310334","display_name":"Ramin Tehranchi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":true,"raw_author_name":"Ramin Tehranchi","raw_affiliation_strings":["Novo Nordisk A/S, Soeburg, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk A/S, Soeburg, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069953991","display_name":"Ampaiwan Chuansumrit","orcid":"https://orcid.org/0000-0003-1230-1591","observed_orcids":["https://orcid.org/0000-0003-1230-1591"]},"institutions":[{"id":"https://openalex.org/I25399158","display_name":"Mahidol University","ror":"https://ror.org/01znkr924","country_code":"TH","type":"education","lineage":["https://openalex.org/I25399158"]},{"id":"https://openalex.org/I4210140007","display_name":"Ramathibodi Hospital","ror":"https://ror.org/04884sy85","country_code":"TH","type":"healthcare","lineage":["https://openalex.org/I4210140007"]}],"countries":["TH"],"is_corresponding":true,"raw_author_name":"Ampaiwan Chuansumrit","raw_affiliation_strings":["Ramathibodi Hospital, Mahidol University, Bangkok, Thailand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ramathibodi Hospital, Mahidol University, Bangkok, Thailand","institution_ids":["https://openalex.org/I25399158","https://openalex.org/I4210140007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051269559","display_name":"Hideji Hanabusa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100768","display_name":"Ogikubo Hospital","ror":"https://ror.org/01639jx86","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210100768"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Hideji Hanabusa","raw_affiliation_strings":["Ogikubo Hospital, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ogikubo Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I4210100768"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070640404","display_name":"Steven R. Lentz","orcid":"https://orcid.org/0000-0002-8885-4718","observed_orcids":["https://orcid.org/0000-0002-8885-4718"]},"institutions":[{"id":"https://openalex.org/I126307644","display_name":"University of Iowa","ror":"https://ror.org/036jqmy94","country_code":"US","type":"education","lineage":["https://openalex.org/I126307644"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven R. Lentz","raw_affiliation_strings":["Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA","institution_ids":["https://openalex.org/I126307644"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087552786","display_name":"Johnny Ndoni Mahlangu","orcid":"https://orcid.org/0000-0001-5781-7669","observed_orcids":["https://orcid.org/0000-0001-5781-7669"]},"institutions":[{"id":"https://openalex.org/I107920810","display_name":"National Health Laboratory Service","ror":"https://ror.org/00znvbk37","country_code":"ZA","type":"government","lineage":["https://openalex.org/I107920810"]},{"id":"https://openalex.org/I192619145","display_name":"University of the Witwatersrand","ror":"https://ror.org/03rp50x72","country_code":"ZA","type":"education","lineage":["https://openalex.org/I192619145"]}],"countries":["ZA"],"is_corresponding":false,"raw_author_name":"Johnny N. Mahlangu","raw_affiliation_strings":["Hemophilia Comprehensive Care Center, Department of Molecular Medicine and Haematology, Faculty of Health Sciences, University of the Witwatersrand and NHLS, Johannesburg, South Africa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hemophilia Comprehensive Care Center, Department of Molecular Medicine and Haematology, Faculty of Health Sciences, University of the Witwatersrand and NHLS, Johannesburg, South Africa","institution_ids":["https://openalex.org/I107920810","https://openalex.org/I192619145"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048888596","display_name":"Evelien P. Mauser\u2010Bunschoten","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018483916","display_name":"University Medical Center Utrecht","ror":"https://ror.org/0575yy874","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I3018483916"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"Evelien Mauser-Bunschoten","raw_affiliation_strings":["University Medical Center Utrecht, Utrecht, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Medical Center Utrecht, Utrecht, Netherlands","institution_ids":["https://openalex.org/I3018483916"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017113740","display_name":"Claude N\u00e9grier","orcid":"https://orcid.org/0000-0002-2905-055X","observed_orcids":["https://orcid.org/0000-0002-2905-055X","https://orcid.org/0000-0003-3569-0366"]},"institutions":[{"id":"https://openalex.org/I100532134","display_name":"Lyon 1 Universit\u00e9","ror":"https://ror.org/029brtt94","country_code":"FR","type":"education","lineage":["https://openalex.org/I100532134","https://openalex.org/I203339264"]},{"id":"https://openalex.org/I4210123600","display_name":"H\u00f4pital Edouard Herriot","ror":"https://ror.org/02qt1p572","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210100596","https://openalex.org/I4210123600"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Claude Negrier","raw_affiliation_strings":["H\u00f4pital Edouard Herriot, University Claude Bernard Lyon 1, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H\u00f4pital Edouard Herriot, University Claude Bernard Lyon 1, Lyon, France","institution_ids":["https://openalex.org/I100532134","https://openalex.org/I4210123600"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079861916","display_name":"Johannes Oldenburg","orcid":"https://orcid.org/0000-0002-1585-4100","observed_orcids":["https://orcid.org/0000-0002-1585-4100","https://orcid.org/0000-0003-3038-2145"]},"institutions":[{"id":"https://openalex.org/I135140700","display_name":"University of Bonn","ror":"https://ror.org/041nas322","country_code":"DE","type":"education","lineage":["https://openalex.org/I135140700"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Johannes Oldenburg","raw_affiliation_strings":["Institute of Experimental Haematology and Transfusion Medicine, Bonn, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Experimental Haematology and Transfusion Medicine, Bonn, Germany","institution_ids":["https://openalex.org/I135140700"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009300900","display_name":"T\u00fcrkan Pat\u0131ro\u011flu","orcid":"https://orcid.org/0000-0003-2471-764X","observed_orcids":["https://orcid.org/0000-0003-2471-764X"]},"institutions":[{"id":"https://openalex.org/I87673952","display_name":"Erciyes University","ror":"https://ror.org/047g8vk19","country_code":"TR","type":"education","lineage":["https://openalex.org/I87673952"]}],"countries":["TR"],"is_corresponding":true,"raw_author_name":"Turkan Patiroglu","raw_affiliation_strings":["Erciyes University Child, Kayseri, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Erciyes University Child, Kayseri, Turkey","institution_ids":["https://openalex.org/I87673952"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035546452","display_name":"Elena Santagostino","orcid":"https://orcid.org/0000-0001-9639-6422","observed_orcids":["https://orcid.org/0000-0001-9639-6422"]},"institutions":[{"id":"https://openalex.org/I2803066834","display_name":"Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico","ror":"https://ror.org/016zn0y21","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I189158943","https://openalex.org/I2803066834","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Elena Santagostino","raw_affiliation_strings":["Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy","institution_ids":["https://openalex.org/I2803066834"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Marek Zak","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":true,"raw_author_name":"Marek Zak","raw_affiliation_strings":["Novo Nordisk A/S, Soeburg, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk A/S, Soeburg, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109220866","display_name":"Fara Abdul Karim","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Fara Abdul Karim","raw_affiliation_strings":["Haemophilia Center, National Blood Centre, Kuala Lumpur, Malaysia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Haemophilia Center, National Blood Centre, Kuala Lumpur, Malaysia","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":11,"institutions_distinct_count":16,"corresponding_author_ids":["https://openalex.org/A5009300900","https://openalex.org/A5035546452","https://openalex.org/A5048888596","https://openalex.org/A5051269559","https://openalex.org/A5065311756","https://openalex.org/A5069953991","https://openalex.org/A5088310334","https://openalex.org/A5109220866"],"corresponding_institution_ids":["https://openalex.org/I189090001","https://openalex.org/I25399158","https://openalex.org/I2803066834","https://openalex.org/I3018483916","https://openalex.org/I4210100768","https://openalex.org/I4210140007","https://openalex.org/I79510175","https://openalex.org/I87673952"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.4313,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.69960968,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"124","issue":"21","first_page":"2846","last_page":"2846"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11280","display_name":"Hemophilia Treatment and Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11280","display_name":"Hemophilia Treatment and Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11917","display_name":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hemophilia-b","display_name":"hemophilia B","score":0.9549999833106995},{"id":"https://openalex.org/keywords/factor-ix","display_name":"factor IX","score":0.703000009059906},{"id":"https://openalex.org/keywords/prophylaxis","display_name":"prophylaxis","score":0.7260000109672546},{"id":"https://openalex.org/keywords/on-demand-treatment","display_name":"on-demand treatment","score":0.6759999990463257},{"id":"https://openalex.org/keywords/bleeding-events","display_name":"bleeding events","score":0.5929999947547913},{"id":"https://openalex.org/keywords/immunogenicity","display_name":"immunogenicity","score":0.7910000085830688},{"id":"https://openalex.org/keywords/factor-ix-inhibitors","display_name":"factor IX inhibitors","score":0.7300000190734863},{"id":"https://openalex.org/keywords/long-term-treatment-safety","display_name":"long-term treatment safety","score":0.6460000276565552},{"id":"https://openalex.org/keywords/factor-ix-activity","display_name":"factor IX activity","score":0.5789999961853027},{"id":"https://openalex.org/keywords/previously-treated-patients","display_name":"previously treated patients","score":0.6800000071525574},{"id":"https://openalex.org/keywords/extension-trial","display_name":"extension trial","score":0.6389999985694885}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8545151352882385},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.6502377986907959},{"id":"https://openalex.org/C2781221834","wikidata":"https://www.wikidata.org/wiki/Q425360","display_name":"Factor IX","level":2,"score":0.5935522317886353},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5698570609092712},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.5030433535575867},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5011458396911621},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.44778168201446533},{"id":"https://openalex.org/C2779526002","wikidata":"https://www.wikidata.org/wiki/Q1642040","display_name":"Hemarthrosis","level":2,"score":0.44027888774871826},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4109615087509155},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.34077221155166626},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v124.21.2846.2846","doi":"https://doi.org/10.1182/blood.v124.21.2846.2846","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v124.21.2846.2846","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2979805398","https://openalex.org/W2291672567","https://openalex.org/W3045933555","https://openalex.org/W1997085090","https://openalex.org/W3022441453","https://openalex.org/W2894432049","https://openalex.org/W2767473423","https://openalex.org/W4391642425","https://openalex.org/W2368669124","https://openalex.org/W2962856511"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Prolongation":[2],"technology":[3],"has":[4],"recently":[5],"been":[6],"employed":[7],"to":[8,40,45,92,115,142,151,186,229,294,370,381,388,404,564],"advance":[9],"the":[10,58,69,78,117,193,200,231,239,267,354,363,392,395,412,469,487,523,554,557],"treatment":[11,48,123,232,347,413],"in":[12,30,126,394,468,493,511],"hemophilia.":[13],"Nonacog":[14],"beta":[15],"pegol":[16],"(N9-GP)":[17],"is":[18,601],"a":[19,26,90,299,309,329,374,417,436,443,461,566],"glycoPEGylated":[20],"recombinant":[21],"factor":[22],"IX":[23],"(rFIX)":[24],"with":[25,104,124,171,175,257,349,373,428,435,476,497,542,571],"significantly":[27,67],"extended":[28],"half-life":[29],"hemophilia":[31,131,163],"B":[32,132,164],"adults":[33],"(Negrier":[34],"et":[35,82],"al.":[36,83],"Blood":[37],"2011),":[38],"up":[39,369],"111":[41],"h,":[42],"as":[43,73,75,266,277,303,305,308],"compared":[44,475],"currently":[46],"available":[47],"options.":[49],"The":[50,107,135,207,551],"pivotal":[51,194,201],"phase":[52,108,195,610],"3":[53,109,196,611],"trial,":[54,111,197,203,368,705],"paradigm\u21222,":[55,198],"demonstrated":[56,89],"that":[57,561],"prophylactic":[59,155,330,495,573],"protection":[60,574],"of":[61,71,102,121,138,145,159,169,178,271,287,315,326,332,353,365,391,419,421,430,449,464,501,553,577,588,644,672,743,764],"40":[62,260,338,371,379,472,515,546],"U/kg":[63,261,336,339,361,380,387,473,480,513,516,544,547],"N9-GP":[64,125,295,333,474,481,562,600],"once":[65,254,340],"weekly":[66,255],"reduced":[68],"risk":[70],"bleeding":[72,79,423,432,447,466,489,527],"well":[74,304],"successfully":[76,426],"controlled":[77],"episodes":[80,424,433,454,467],"(Collins":[81],"JTH":[84],"(Suppl.2)":[85],"2013).":[86],"It":[87],"also":[88],"potential":[91],"improve":[93,100],"clinical":[94,244,612],"outcomes,":[95],"reduce":[96],"joint":[97],"damage":[98],"and":[99,119,128,154,157,190,214,246,506,514,534,545,568,575,636,716,735],"quality":[101],"life":[103],"fewer":[105],"injections.":[106],"extension":[110,367],"paradigm\u21224,":[112],"was":[113,141,209,264,457,460,529],"designed":[114],"investigate":[116],"safety":[118,158,409],"efficacy":[120,156],"long-term":[122],"severe":[127,130],"moderately":[129],"patients.":[133],"Aims:":[134],"primary":[136,268],"objective":[137],"this":[139,366],"trial":[140,208,223,235,240,396,555,613,707],"evaluate":[143],"immunogenicity":[144],"N9-GP.":[146,160,262],"Key":[147],"secondary":[148],"objectives":[149],"were":[150,205,227,318,343,400,425,491],"assess":[152],"therapeutic":[153],"Methods:":[161],"71":[162,316],"patients":[165,317,355,393,440,470,477,540],"above":[166],"12":[167,323],"years":[168],"age":[170],"\u22642%":[172],"FIX":[173,188,275,306],"activity,":[174],"no":[176,401],"history":[177],"inhibitors,":[179],"at":[180,234,321,362],"least":[181,322],"150":[182],"exposures":[183],"days":[184],"(ED)":[185],"other":[187],"products,":[189],"who":[191],"completed":[192],"or":[199,237,253,259,337,359,384,407,590,646,674,745,766],"surgery":[202],"paradigm\u21223,":[204],"included.":[206],"approved":[210],"by":[211],"local":[212],"IRB/REC":[213],"all":[215,422,431],"participants":[216],"signed":[217],"an":[218,585,641,669,740,761],"informed":[219],"consent":[220],"before":[221],"any":[222],"related":[224],"activity.":[225],"Patients":[226],"allowed":[228],"change":[230],"regimen":[233,331],"start":[236,364],"during":[238],"based":[241,297],"on":[242,298,441,471,478,584,640,668,739,760],"their":[243],"manifestation":[245],"investigator":[247],"recommendation;":[248],"options":[249],"included":[250,285],"on-demand":[251,358],"treatment,":[252],"prophylaxis":[256,290],"10":[258,335,360,382,386,479,512,543],"Immunogenicity":[263],"evaluated":[265],"endpoint;":[269],"incidence":[270],"inhibitory":[272],"antibodies":[273],"against":[274],"defined":[276],"titer":[278],"\u22650.6":[279],"Bethesda":[280],"Units":[281],"(BU).":[282],"Efficacy":[283],"endpoints":[284],"frequency":[286],"bleeds":[288,521],"among":[289,539],"patients,":[291],"hemostatic":[292],"response":[293],"infusion":[296],"4-point":[300],"categorical":[301],"scale,":[302],"activity":[307],"surrogate":[310],"marker.":[311],"Results:":[312],"A":[313],"total":[314,418],"treated":[319,434,541],"for":[320],"months,":[324],"67":[325],"whom":[327],"received":[328],"either":[334],"weekly;":[341],"there":[342],"considerable":[344],"movements":[345],"between":[346,411],"arms,":[348],"approximately":[350],"one":[351],"third":[352],"moving":[356,377],"from":[357,378,385,559],"U/kg,":[372,383],"smaller":[375],"proportion":[376,463],"on-demand.":[389],"None":[390],"developed":[397],"inhibitors.":[398],"There":[399,459],"differences":[402],"relating":[403],"adverse":[405],"events":[406],"standard":[408],"parameters":[410],"groups.":[414],"In":[415],"paradigm\u21224":[416],"94.6%":[420],"treated,":[427],"87.9%":[429],"single":[437],"infusion.":[438],"Among":[439],"prophylaxis,":[442],"median":[444,498,524],"(IQR)":[445,499,525],"annualized":[446,488,526],"rate":[448,528],"1.1":[450,530],"(0.0":[451,503,508,531,536],"\u2013":[452,504,509,532,537],"2.2)":[453,533],"per":[455],"year":[456],"observed.":[458],"higher":[462],"traumatic":[465],"(57.1%":[482],"vs.":[483],"28.6%,":[484],"respectively),":[485],"though":[486],"rates":[490],"similar":[492],"both":[494],"groups,":[496],"ABR":[500],"0.0":[502,507,535],"1.0)":[505,538],"1.1)":[510],"N9-GP,":[517,548],"respectively.":[518,549],"For":[519],"spontaneous":[520],"only,":[522],"Conclusion:":[550],"outcome":[552],"confirmed":[556],"results":[558],"paradigm\u21222":[560],"appeared":[563],"have":[565],"safe":[567],"well-tolerated":[569],"profile":[570],"good":[572],"control":[576],"bleeding.":[578],"Disclosures":[579],"Young:":[580],"Novo":[581,630,656,663,680,691,702,729,753],"Nordisk:":[582,616,626,650,681,692,703],"Membership":[583,639,667,738,759],"entity's":[586,642,670,741,762],"Board":[587,643,671,742,763],"Directors":[589,645,673,744,765],"advisory":[591,647,675,746,767],"committees,":[592,747,768],"Research":[593,652,682,698,720,748,769],"Funding,":[594,770],"Speakers":[595,659,693,771],"Bureau.":[596,772],"Off":[597],"Label":[598],"Use:":[599],"not":[602],"yet":[603],"FDA":[604],"approved.":[605],"Information":[606],"provided":[607],"will":[608],"discuss":[609],"data..":[614],"Collins:Novo":[615],"Consultancy,":[617,651,718],"Honoraria.":[618,627],"Tehranchi:Novo":[619],"Nordisk":[620,774],"A/S:":[621,775],"Employment,":[622],"Shareholder":[623],"Other.":[624,708],"Chuansumrit:Novo":[625],"Hanabusa:Baxter":[628],"Healthcare,":[629],"Nordisk,":[631,657,664,710,730,754],"Bayer,":[632,662,677,687,712,723,751],"Pfizer,":[633,665],"Biogen":[634,678,724],"Idec":[635],"KaketsuKen:":[637],"Honoraria,":[638,719,737],"committees.":[648],"Lentz:Novo":[649],"Funding.":[653,683,721,749],"Mahlangu:Biogen":[654],"Idec,":[655,679,725],"Biotest:":[658,758],"Bureau;":[660,694],"Amgen,":[661],"Genentech:":[666],"committees;":[676],"Mauser-Bunschoten:Sanquin,":[684],"CSL":[685,696,713,755],"Behring,":[686,714,756],"Baxter,":[688,711,752],"Griffols,":[689],"LFB,":[690],"Sanquin,":[695],"Behring:":[697],"Funding;":[699],"Baxter:":[700],"Consultancy;":[701],"Registration":[704,706],"Negrier:Novo":[709],"LFB":[715],"Pfizer:":[717,736],"Oldenburg:Baxter,":[722],"Biotest,":[726],"CSL-Behring,":[727],"Grifols,":[728,757],"Octapharma,":[731],"Swedish":[732],"Orphan":[733],"Biovitrum":[734],"Santagostino:Pfizer,":[750],"Zak:Novo":[773],"Employment.":[776]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-12-16T00:00:00"}